Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raptiva in Discoid Lupus Erythematosus of the Scalp
NCT00308204Phase 2Withdrawn
- Sponsor
- Cleveland Clinic
- Start
- Mar 2006
- Primary completion
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of efalizumab in discoid lupus erythematosus (DLE), sponsored by Cleveland Clinic. Planned start Mar 2006; status: withdrawn.
02
Drugs
efalizumab
03
Conditions
discoid lupus erythematosus (DLE)
Beyond the preview
Go deeper on NCT00308204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308204.